Bausch Health Companies (BHC) PT Lowered to $14 at Stifel
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
Go back to Bausch Health Companies (BHC) PT Lowered to $14 at Stifel
November 3, 2022 11:45 AM EDT
Cowen analyst Ken Cacciatore lowered the price target on Bausch Health Companies (NYSE: BHC) to $35.00 (from $40.00) while maintaining a Outperform rating following results.
The analyst commented, "Q3 revs reached $2.05B, in line, driven by recovery in all major segments including Salix, Solta, and... More
November 3, 2022 7:17 AM EDT
Bausch Health Co. Inc. (NYSE: BHC) reported Q3 EPS of $1.10, $0.16 better than the analyst estimate of $0.94. Revenue for the quarter came in at $2.05 billion versus the consensus estimate of $2.07 billion.
GUIDANCE:
Bausch Health Co. Inc. sees FY2022 revenue of $8-8.17... More
November 2, 2022 10:09 AM EDT
Bausch Health Co. Inc. (NYSE: BHC) November weekly call option implied volatility is at 161, November is at 111; compared to its 52-week range of 33 to 243 into the expected release of quarter results on November 3.
...
More
November 2, 2022 4:27 AM EDT
Bausch Health Co. Inc. (NYSE: BHC) November weekly 7 straddle priced for a move of 16% into the expected release of quarter results on November 3.
...
More
